Life science News and Research

RSS

BioMed Realty Trust receives additional space at Landmark under new lease agreement

BioMed Realty Trust, Inc. announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) for approximately 131,000 square feet of additional, newly-constructed laboratory and office space at The Landmark at Eastview campus in Tarrytown, New York.

4 Dec 2009

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful second closing of its Series A equity financing round. The Company raised an additional EUR 3.0 million (~USD 4.5 million) from two leading life science investors, Credit Agricole Private Equity and VIB (the prestigious Flemish research institute).

3 Dec 2009

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

Veeco Instruments Inc., the leading provider of atomic force microscope (AFM) instrumentation to the Research and Industrial communities, announced today the introduction of two patent-pending AFM scan modes, ScanAsyst™ and PeakForce™ QNM™.

2 Dec 2009

TAP and pharma company team up to design Sonata, a unique system to speed drug development

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, is delighted to announce that its Advanced Projects Group has partnered with a leading pharma company to successfully design and deliver Sonata™, a unique system for automated culturing and processing of cell lines in shake flasks.

1 Dec 2009

Scientists and engineers explore synergies in moving oil and pumping blood

Scientists and engineers from two of the nation's largest industries - medicine and energy - will come together Dec. 7 with leading academicians to explore the synergies in moving oil and pumping blood.

1 Dec 2009

Xybion completes the acquisition of all operating assets of Amadeus Solutions

Xybion Corporation announced today that through the creation of a wholly owned Quebec Corporation, Services Informatiques Xybion, it has completed the acquisition of all operating assets of Quebec City based Amadeus Solutions, a leader in the development of enterprise governance, risk, compliance and quality management software solutions, from DECIMAL, a corporate performance management organization headquartered in Montreal.

1 Dec 2009

Tennessee Biotechnology Association to host workshop on biotechnology industry

The Tennessee Biotechnology Association and its Graduate Alliance are jointly hosting an afternoon of biotech, business, and law on December 7th, 2009. This event will be held at Belmont University with a reception at 5pm sponsored by i3 Research.

25 Nov 2009

Ocimum Biosolutions' Biotracker awarded caBIG Bronze Compatibility Certification

Ocimum Biosolutions today announced that its specialty life science Laboratory Information Management System (LIMS), Biotracker™ has been awarded the prestigious caBIG® (cancer Biomedical Informatics Grid®) Bronze Compatibility Certification by the National Cancer Institute, an institute of the National Institutes of Health, U.S. Department of Health and Human Services.

24 Nov 2009

TAP delivers customized automated protein purification system in collaboration with a European major

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications, today announced its Advanced Projects Group has successfully collaborated with a major European antibody therapeutics company to deliver a custom automated protein purification and concentration system helping the company accelerate its pre-clinical research.

24 Nov 2009

Millipore completes acquisition of the remaining 60% ownership of its joint-venture in India

Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it has acquired the remaining 60 percent ownership of its joint-venture in India, Millipore India Pvt. Ltd. The new subsidiary will enable Millipore to invest in initiatives that will drive growth and expand its leadership in India’s thriving life science market.

23 Nov 2009

New multimedia application from ASM

Want to get the latest microbiology news, podcasts and video content in the palm of your hand? Now there is an app for that. A new application from the American Society for Microbiology (ASM) allows users to access and interact with audio and video content on MicrobeWorld, its award winning multimedia website, directly from their iPhones and iPod Touches.

20 Nov 2009

Image of a water flea wins top prize in the 2009 Olympus BioScapes Digital Imaging Competition

A glowing, eerily beautiful image of a water flea with its radiant green "crown of thorns" took top prize in the 2009 Olympus BioScapes Digital Imaging Competition®, the world's foremost forum for showcasing microscope photos and movies of life science subjects. Dr. Jan Michels, a zoologist at the University of Albrecht, Kiel, Germany, took top honors for the image of a water flea, with its defensive "crown of thorns" to protect it against predators. The image reveals not only the exoskeleton, but also interior detail down to the nuclei within its cells, seen as tiny, glowing blue dots. This

From Evident Corporation - Life Sciences 20 Nov 2009

EIF enters into co-investment agreement with Karolinska Development

Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies.

20 Nov 2009

Unique life science-focused application for social media site launched

Sigma-Aldrich® today announced the launch of a unique life science-focused application for the social media site, Facebook. Developed and marketed by Sigma® Life Science, the 'What's Your Favorite Gene?' application is the first and currently only application of its kind available on Facebook, and provides a platform that can enable scientists and researchers to network with each other and facilitate discussion based on their favorite genes, identifiable via gene functionality and biological pathways.

19 Nov 2009

Lathian Health announces the availability of proprietary longitudinal data assets to life science companies

After aggregating and mining physician responses to ePromotion campaigns spanning more than 115 brands, 64 therapeutic conditions and 30 specialties, Lathian Health today announced the availability of its proprietary longitudinal data assets to life science companies.

19 Nov 2009

IBM scientists work with Rizzoli Orthopedic Institute to use BioMIMS to treat genetic skeletal diseases

IBM ( IBM) announced today that its Research scientists are working with the Rizzoli Orthopedic Institute, in Bologna, Italy, to use information technology to better address treatment and research for rare genetic skeletal diseases.

18 Nov 2009

End of life research focuses to improve psychological outlook of severely ill patients

Hospice workers have watched patients emerge from comas and cling to life long enough to tell someone they love or forgive them.

18 Nov 2009

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

Abbott and BG Medicine, Inc. today announced a development and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure. The assay will be developed for Abbott's ARCHITECT immunochemistry instrument platform, specifically the company's i1000SR and i2000SR instruments. The agreement grants Abbott a license to BG Medicine's intellectual property related to galectin-3.

17 Nov 2009

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Agilent Technologies Inc. today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents.

17 Nov 2009

Life science News and Research

BioMed Realty Trust receives additional space at Landmark under new lease agreement

arGEN-X to develop its SIMPLE Antibody engine with completed EUR 12.5M Series A equity financing

Veeco Instruments introduces ScanAsyst and PeakForce QNM scan modes

TAP and pharma company team up to design Sonata, a unique system to speed drug development

Scientists and engineers explore synergies in moving oil and pumping blood

Xybion completes the acquisition of all operating assets of Amadeus Solutions

Tennessee Biotechnology Association to host workshop on biotechnology industry

Ocimum Biosolutions' Biotracker awarded caBIG Bronze Compatibility Certification

TAP delivers customized automated protein purification system in collaboration with a European major

Millipore completes acquisition of the remaining 60% ownership of its joint-venture in India

New multimedia application from ASM

Image of a water flea wins top prize in the 2009 Olympus BioScapes Digital Imaging Competition

EIF enters into co-investment agreement with Karolinska Development

Unique life science-focused application for social media site launched

Lathian Health announces the availability of proprietary longitudinal data assets to life science companies

IBM scientists work with Rizzoli Orthopedic Institute to use BioMIMS to treat genetic skeletal diseases

End of life research focuses to improve psychological outlook of severely ill patients

Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Agilent Technologies acquires MassCode Tag technology from Eurofins MWG Operon

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News